Skip to main content
SpringerLink
Log in
Book cover

Implantable Cardioverter Defibrillator Therapy: The Engineering-Clinical Interface

  • Book
  • © 1996

Overview

Editors:
  1. Mark W. Kroll

    1. Tachycardia Business Unit, Pacesetter Inc., A St. Jude Medical Company, Sylmar, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Michael H. Lehmann

    1. Wayne State University School of Medicine, Sinai Hospital, Detroit, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Developments in Cardiovascular Medicine (DICM, volume 188)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (24 chapters)

  1. Front Matter

    Pages i-xxii
    Download chapter PDF

  2. Sudden Cardiac Death

    • Masood Akhtar, Mohammad R. Jazayeri, Jasbir S. Sra, Zalmen Blanck, Sanjay Deshpande, Anwer Dhala et al.
    Pages 1-15

  3. History of the ICD

    • William S. Staewen, Morton M. Mower
    Pages 17-30

  4. The Electrophysiological Effects of Defibrillation Shocks

    • Stephen M. Dillon
    Pages 31-61

  5. Defining the Defibrillation Dosage

    • Mark W. Kroll, Michael H. Lehmann, Patrick J. Tchou
    Pages 63-88

  6. The Defibrillation Threshold

    • Igor Singer, Douglas Lang
    Pages 89-129

  7. Pathways for Defibrillation Current

    • Michael J. Kallok
    Pages 131-146

  8. The Defibrillation Waveform

    • Susan M. Blanchard, Raymond E. Ideker, Randolph A. S. Cooper, J. Marcus Wharton
    Pages 147-161

  9. The System

    • C. G. Jerry Supino
    Pages 163-172

  10. Leads for the ICD

    • Randall S. Nelson, Byron L. Gilman, J. Edward Shapland, Michael H. Lehmann
    Pages 173-204

  11. The Battery

    • Curtis F. Holmes
    Pages 205-221

  12. The High Voltage Capacitor

    • Joel B. Ennis, Mark W. Kroll
    Pages 223-239

  13. The Pulse Generator

    • Randall S. Nelson
    Pages 241-255

  14. High Power Circuitry

    • Stan M. Bach Jr., Paul Monroe
    Pages 257-273

  15. The Amplifier: Sensing the Depolarization

    • Dennis A. Brumwell, Kai Kroll, Michael H. Lehmann
    Pages 275-302

  16. Tachyarrhythmia Detection

    • Stan M. Bach Jr., Michael H. Lehmann, Mark W. Kroll
    Pages 303-323

  17. Anti-Tachycardia Pacing and Cardioversion

    • Michael L. Hardage, Michael B. Sweeney
    Pages 325-342

  18. Implantation: Pre-operative Evaluation to Discharge

    • Wolfram Grimm, Francis E. Marchlinski
    Pages 343-363

  19. ICD Infection Avoidance: Science, Art, Discipline

    • Richard B. Shepard, Andrew E. Epstein
    Pages 365-388

  20. Safety Margins for Sensing and Detection: Programming Tradeoffs

    • Walter Olson
    Pages 389-420
Back to top

Keywords

About this book

HE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, or T"lCD," is arguably the most technologically challenging type of therapy that physicians utilize today. At the same time, engineers who design ICDs are being called upon by clinicians to extend even further the technological envelope in quest of building the "ideal" device. To the extent, however, that physicians who utilize ICDs are not sufficiently comfortable with or familiar with the engineering principles that guide ICD function, the full clinical potential of even an ideal device will not be realized. In comple­ mentary fashion, engineers require as full an appreciation as possi­ ble of the real world "boundary conditions" and clinical impact of various ICD features, if the latter are truly to be perfected. This book is intended to serve as an educational tool to foster mutual understanding and communication among physicians, engineers, and other professionals involved in ICD therapy, with the ultimate purpose of enhancing patient care. The highly varied backgrounds of such a diverse audience posed obvious challenges in the preparation of this volume. Given the overwhelmingly greater involvement of clinicians in the day-to­ day management and follow-up of ICD recipients, we gave high priority to the presentation of oftentimes complex yet relevant engi­ neering concepts in a manner that could be understandable to most clinicians.

Editors and Affiliations

  • Tachycardia Business Unit, Pacesetter Inc., A St. Jude Medical Company, Sylmar, USA

    Mark W. Kroll

  • Wayne State University School of Medicine, Sinai Hospital, Detroit, USA

    Michael H. Lehmann

Bibliographic Information

  • Book Title: Implantable Cardioverter Defibrillator Therapy: The Engineering-Clinical Interface

  • Editors: Mark W. Kroll, Michael H. Lehmann

  • Series Title: Developments in Cardiovascular Medicine

  • DOI: https://doi.org/10.1007/978-1-4615-6345-7

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 1996

  • Hardcover ISBN: 978-0-7923-4300-4Published: 30 November 1996

  • Softcover ISBN: 978-1-4613-7914-0Published: 13 October 2012

  • eBook ISBN: 978-1-4615-6345-7Published: 06 December 2012

  • Series ISSN: 0166-9842

  • Edition Number: 1

  • Number of Pages: XXII, 585

  • Topics: Cardiology

Publish with us

Policies and ethics

Back to top

Search

Navigation